BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12691142)

  • 1. Acute megakaryoblastic leukaemia: a national clinical and biological study of 53 adult and childhood cases by the Groupe Français d'Hématologie Cellulaire (GFHC).
    Duchayne E; Fenneteau O; Pages MP; Sainty D; Arnoulet C; Dastugue N; Garand R; Flandrin G; ;
    Leuk Lymphoma; 2003 Jan; 44(1):49-58. PubMed ID: 12691142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytogenetic profile of childhood and adult megakaryoblastic leukemia (M7): a study of the Groupe Français de Cytogénétique Hématologique (GFCH).
    Dastugue N; Lafage-Pochitaloff M; Pagès MP; Radford I; Bastard C; Talmant P; Mozziconacci MJ; Léonard C; Bilhou-Nabéra C; Cabrol C; Capodano AM; Cornillet-Lefebvre P; Lessard M; Mugneret F; Pérot C; Taviaux S; Fenneteaux O; Duchayne E; Berger R;
    Blood; 2002 Jul; 100(2):618-26. PubMed ID: 12091356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute megakaryoblastic leukemia in children and adolescents: a retrospective analysis of 24 cases.
    Ribeiro RC; Oliveira MS; Fairclough D; Hurwitz C; Mirro J; Behm FG; Head D; Silva ML; Raimondi SC; Crist WM
    Leuk Lymphoma; 1993 Jul; 10(4-5):299-306. PubMed ID: 8220128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD34+ megakaryoblastic leukaemic cells are CD38-, but CD61+ and glycophorin A+: improved criteria for diagnosis of AML-M7?
    Helleberg C; Knudsen H; Hansen PB; Nikolajsen K; Kjaersgaard E; Ralfkiaer E; Johnsen HE
    Leukemia; 1997 Jun; 11(6):830-4. PubMed ID: 9177436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blast cell deficiency of CD11a as a marker of acute megakaryoblastic leukemia and transient myeloproliferative disease in children with and without Down syndrome.
    Boztug H; Schumich A; Pötschger U; Mühlegger N; Kolenova A; Reinhardt K; Dworzak M
    Cytometry B Clin Cytom; 2013; 84(6):370-8. PubMed ID: 23450818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult acute megakaryocytic leukemia: an analysis of 37 patients treated at M.D. Anderson Cancer Center.
    Oki Y; Kantarjian HM; Zhou X; Cortes J; Faderl S; Verstovsek S; O'Brien S; Koller C; Beran M; Bekele BN; Pierce S; Thomas D; Ravandi F; Wierda WG; Giles F; Ferrajoli A; Jabbour E; Keating MJ; Bueso-Ramos CE; Estey E; Garcia-Manero G
    Blood; 2006 Feb; 107(3):880-4. PubMed ID: 16123215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multipotent stem cell involvement in megakaryoblastic leukemia: cytologic and cytogenetic evidence in 15 patients.
    Cuneo A; Mecucci C; Kerim S; Vandenberghe E; Dal Cin P; Van Orshoven A; Rodhain J; Bosly A; Michaux JL; Martiat P
    Blood; 1989 Oct; 74(5):1781-90. PubMed ID: 2790202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The translocation t(1;22)(p13;q13) is a nonrandom marker specifically associated with acute megakaryocytic leukemia in young children.
    Lion T; Haas OA; Harbott J; Bannier E; Ritterbach J; Jankovic M; Fink FM; Stojimirovic A; Herrmann J; Riehm HJ
    Blood; 1992 Jun; 79(12):3325-30. PubMed ID: 1596573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute megakaryoblastic leukaemia: a clinico-haematological profile of five cases.
    Shukla J; Rai S; Singh VP
    Indian J Pathol Microbiol; 2004 Apr; 47(2):266-8. PubMed ID: 16295495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. M0 AML, clinical and biologic features of the disease, including AML1 gene mutations: a report of 59 cases by the Groupe Français d'Hématologie Cellulaire (GFHC) and the Groupe Français de Cytogénétique Hématologique (GFCH).
    Roumier C; Eclache V; Imbert M; Davi F; MacIntyre E; Garand R; Talmant P; Lepelley P; Lai JL; Casasnovas O; Maynadie M; Mugneret F; Bilhou-Naberra C; Valensi F; Radford I; Mozziconacci MJ; Arnoulet C; Duchayne E; Dastugue N; Cornillet P; Daliphard S; Garnache F; Boudjerra N; Jouault H; Fenneteau O; Pedron B; Berger R; Flandrin G; Fenaux P; Preudhomme C; ;
    Blood; 2003 Feb; 101(4):1277-83. PubMed ID: 12393381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute megakaryoblastic leukemia.
    Gassmann W; Löffler H
    Leuk Lymphoma; 1995; 18 Suppl 1():69-73. PubMed ID: 7496359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biology, clinical, and hematologic features of acute megakaryoblastic leukemia in children.
    Paredes-Aguilera R; Romero-Guzman L; Lopez-Santiago N; Trejo RA
    Am J Hematol; 2003 Jun; 73(2):71-80. PubMed ID: 12749007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation induction of blast cells in two cases of childhood acute megakaryoblastic leukemia in vitro by interleukin-3 and interleukin-6: an ultrastructural cytochemical study.
    Miyauchi J; Sugita K; Okui M; Taguchi N; Clark SC; Shimizu K
    J Cell Physiol; 1991 Sep; 148(3):404-13. PubMed ID: 1655816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Massive periosteal reaction a presenting feature of acute megakaryocytic leukemia.
    Ueda T; Ito Y; Maeda M; Fukunaga Y
    Pediatr Int; 2007 Dec; 49(6):1015-7. PubMed ID: 18045316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute myeloid leukemia in children with Down syndrome].
    Creutzig U; Ritter J; Ludwig WD; Niemeyer C; Reinisch I; Stollmann-Gibbels B; Zimmermann M; Harbott J
    Klin Padiatr; 1995; 207(4):136-44. PubMed ID: 7564143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of acute megakaryoblastic leukaemia (FAB M7), a rare type of acute myeloid leukemia (AML), in a teenager.
    Olatunji PO; Ojo OT; Bello FO; Bakare BY; Olatunji AO
    Malawi Med J; 2018 Dec; 30(4):298-301. PubMed ID: 31798811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrastructural and ultracytochemical differences between megakaryoblastic leukemia in children and adults. Analysis of 49 patients.
    Eguchi M; Ozawa T; Sakakibara H; Sugita K; Iwama Y; Furukawa T
    Cancer; 1992 Jul; 70(2):451-8. PubMed ID: 1319816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of childhood myelodysplastic syndrome, AML FAB M6 or M7, CCG 2891: report from the Children's Oncology Group.
    Barnard DR; Alonzo TA; Gerbing RB; Lange B; Woods WG;
    Pediatr Blood Cancer; 2007 Jul; 49(1):17-22. PubMed ID: 16856158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimally differentiated erythroleukaemia (AML M6 'variant'): a rare subset of AML distinct from AML M6. Groupe Français d'Hématologie Cellulaire.
    Garand R; Duchayne E; Blanchard D; Robillard N; Kuhlein E; Fenneteau O; Salomon-Nguyen F; Grange MJ; Rousselot P; Demur C
    Br J Haematol; 1995 Aug; 90(4):868-75. PubMed ID: 7669665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A t(1;22)(p13;q13) in four children with acute megakaryoblastic leukemia (M7), two with Down syndrome.
    Trejo RM; Aguilera RP; Nieto S; Kofman S
    Cancer Genet Cytogenet; 2000 Jul; 120(2):160-2. PubMed ID: 10942809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.